Sector · updated 2026-05-18
199 Healthcare stocks down from a 52-week high.
Across Healthcare, 105 names are on the Red List, 51 on Amber, and 43 on Watch. The median Healthcare decline is -36.1%. Worst in sector: OPRX (-77.1%). Tiering is computed daily from decline depth, decline sigma, and time-frame continuity — price action only, not fundamentals.
105Red List
51Amber
43Watch
| Tier | Ticker | Company | Decline | Sigma | TFC | Price | Trigger |
|---|---|---|---|---|---|---|---|
| Red List |  OPRX |
OptimizeRx Corporation | -77.1% | 6.7σ | 2/5 | $5.09 | decline depth |
| Red List |  WGS |
GeneDx Holdings Corp. | -75.0% | 3.6σ | 4/5 | $42.69 | decline depth |
| Red List |  UPB |
Upstream Bio, Inc. | -74.7% | 5.7σ | 4/5 | $8.51 | decline depth |
| Red List |  DOCS |
Doximity, Inc. | -74.4% | 4.8σ | 3/5 | $19.58 | decline depth |
| Red List |  MLTX |
MoonLake Immunotherapeutics | -73.8% | 6.0σ | 1/5 | $16.44 | decline depth |
| Red List |  INSP |
Inspire Medical Systems, Inc. | -72.7% | 6.7σ | 5/5 | $41.83 | decline depth |
| Red ListRecovering |  PHR |
Phreesia, Inc. | -72.3% | 4.2σ | 4/5 | $9.08 | decline depth |
| Red List |  ARCT |
Arcturus Therapeutics Holdings | -70.9% | 6.7σ | 2/5 | $7.03 | decline depth |
| Red List |  WVE |
Wave Life Sciences Ltd. | -70.5% | 5.6σ | 3/5 | $6.40 | decline depth |
| Red List |  QDEL |
QuidelOrtho Corporation | -69.5% | 4.2σ | 3/5 | $10.84 | decline depth |
| Red List |  HIMS |
Hims & Hers Health, Inc. | -68.3% | 5.1σ | 4/5 | $22.29 | decline depth |
| Red List |  QURE |
uniQure N.V. | -65.1% | 2.7σ | 2/5 | $24.93 | decline depth |
| Red List |  RGNX |
REGENXBIO Inc. | -65.1% | 5.5σ | 3/5 | $5.65 | decline depth |
| Red List |  OLMA |
Olema Pharmaceuticals, Inc. | -64.4% | 8.9σ | 3/5 | $12.90 | decline depth |
| Red List |  CLPT |
ClearPoint Neuro Inc. | -63.0% | 3.5σ | 3/5 | $11.13 | decline depth |
| Red ListRecovering |  ADMA |
ADMA Biologics Inc | -62.5% | 6.4σ | 5/5 | $8.38 | decline depth |
| Red List |  PRGO |
Perrigo Company plc | -62.4% | 5.5σ | 3/5 | $10.68 | decline depth |
| Red List |  REPL |
Replimune Group, Inc. | -62.2% | 0.8σ | 2/5 | $5.01 | decline depth |
| Red List |  ZBIO |
Zenas BioPharma, Inc. | -62.1% | 4.8σ | 2/5 | $16.91 | decline depth |
| Red List |  SRPT |
Sarepta Therapeutics, Inc. | -61.5% | 8.2σ | 1/5 | $17.01 | decline depth |
| Red List |  SPRY |
ARS Pharmaceuticals, Inc. | -61.4% | 7.0σ | 3/5 | $7.30 | decline depth |
| Red List |  FULC |
Fulcrum Therapeutics, Inc. | -61.3% | 7.4σ | 4/5 | $6.09 | decline depth |
| Red List |  PRCT |
PROCEPT BioRobotics Corporation | -61.1% | 3.1σ | 3/5 | $26.01 | decline depth |
| Red List |  AZTA |
Azenta, Inc. | -61.1% | 6.7σ | 4/5 | $16.24 | decline depth |
| Red List |  ALGS |
Aligos Therapeutics, Inc. | -60.8% | 4.7σ | 2/5 | $5.36 | decline depth |
| Red ListRecovering |  JANX |
Janux Therapeutics, Inc. | -60.3% | 7.7σ | 4/5 | $14.03 | decline depth |
| Red ListRecovering |  SLP |
Simulations Plus, Inc. | -59.5% | 5.5σ | 4/5 | $13.78 | decline depth |
| Red List |  TEM |
Tempus AI, Inc. | -58.2% | 6.7σ | 2/5 | $43.62 | decline depth |
| Red List |  DNA |
Ginkgo Bioworks Holdings, Inc. | -58.1% | 4.8σ | 2/5 | $7.37 | decline depth |
| Red List |  PODD |
Insulet Corporation | -57.0% | 5.9σ | 4/5 | $152.49 | decline depth |
| Red ListRecovering |  SDGR |
Schrodinger, Inc. | -56.4% | 3.5σ | 4/5 | $12.05 | decline depth |
| Red ListRecovering |  CSTL |
Castle Biosciences, Inc. | -56.4% | 5.0σ | 2/5 | $19.32 | decline depth |
| Red ListRecovering |  TMDX |
TransMedics Group, Inc. | -56.2% | 7.6σ | 3/5 | $68.34 | decline depth |
| Red List |  RNAC |
Cartesian Therapeutics, Inc. | -55.8% | 4.7σ | 3/5 | $6.89 | decline depth |
| Red List |  WAY |
Waystar Holding Corp. | -55.3% | 7.7σ | 4/5 | $18.55 | decline depth |
| Red List |  NTLA |
Intellia Therapeutics, Inc. | -55.1% | 5.0σ | 2/5 | $12.69 | decline depth |
| Red List |  KROS |
Keros Therapeutics, Inc. | -54.9% | 5.6σ | 2/5 | $10.16 | decline depth |
| Red List |  CRVS |
Corvus Pharmaceuticals, Inc. | -54.7% | 6.7σ | 2/5 | $12.21 | decline depth |
| Red ListRecovering |  CRMD |
CorMedix Inc. | -54.6% | 5.1σ | 2/5 | $7.91 | decline depth |
| Red List |  TNDM |
Tandem Diabetes Care, Inc. | -54.4% | 7.5σ | 1/5 | $13.53 | decline depth |
| Red List |  BHVN |
Biohaven Ltd. | -54.3% | 6.2σ | 3/5 | $8.49 | decline depth |
| Red List |  VRDN |
Viridian Therapeutics, Inc. | -53.0% | 2.7σ | 3/5 | $16.10 | decline depth |
| Red List |  AVTR |
Avantor, Inc. | -52.3% | 5.3σ | 4/5 | $7.60 | decline depth |
| Red List |  ATRA |
Atara Biotherapeutics, Inc. | -52.2% | 1.4σ | 3/5 | $9.15 | decline depth |
| Red List |  CRBP |
Corbus Pharmaceuticals Holdings | -51.6% | 5.3σ | 2/5 | $9.95 | decline depth |
| Red ListRecovering |  AORT |
Artivion, Inc. | -50.8% | 6.2σ | 3/5 | $23.76 | decline depth |
| Red ListRecovering |  WEAV |
Weave Communications, Inc. | -50.0% | 3.1σ | 5/5 | $5.44 | decline depth |
| Red List |  INSM |
Insmed Incorporated | -49.6% | 4.4σ | 3/5 | $107.15 | decline depth |
| Red List |  OCUL |
Ocular Therapeutix, Inc. | -49.0% | 5.9σ | 3/5 | $8.38 | decline depth |
| Red ListRecovering |  FLGT |
Fulgent Genetics, Inc. | -48.9% | 1.5σ | 3/5 | $15.85 | decline depth |
| Red ListRecovering |  GRAL |
GRAIL, Inc. | -48.9% | 1.6σ | 2/5 | $60.71 | decline depth |
| Red List |  SMMT |
Summit Therapeutics Inc. | -48.3% | 6.7σ | 3/5 | $16.02 | decline depth |
| Red List |  PBH |
Prestige Consumer Healthcare In | -47.9% | 7.3σ | 2/5 | $46.60 | decline depth |
| Red List |  IRTC |
iRhythm Holdings, Inc. | -47.7% | 4.5σ | 3/5 | $110.94 | decline depth |
| Red List |  CVRX |
CVRx, Inc. | -47.4% | 4.0σ | 2/5 | $5.94 | decline depth |
| Red ListRecovering |  VEEV |
Veeva Systems Inc. | -47.2% | 3.2σ | 4/5 | $163.85 | decline depth |
| Red List |  ORIC |
Oric Pharmaceuticals, Inc. | -46.9% | 12.6σ | 2/5 | $7.93 | decline depth |
| Red ListRecovering |  OPCH |
Option Care Health, Inc. | -46.5% | 5.6σ | 2/5 | $19.69 | decline depth |
| Red List |  ICLR |
ICON plc | -46.1% | 2.8σ | 2/5 | $113.78 | decline depth |
| Red List |  NVO |
Novo Nordisk A/S | -45.6% | 3.2σ | 3/5 | $44.28 | decline depth |
| Red List |  DMAC |
DiaMedica Therapeutics Inc. | -45.5% | 5.5σ | 2/5 | $5.68 | decline depth |
| Red List |  RIGL |
Rigel Pharmaceuticals, Inc. | -45.2% | 3.3σ | 3/5 | $28.61 | decline depth |
| Red List |  AMPH |
Amphastar Pharmaceuticals, Inc. | -45.0% | 5.6σ | 4/5 | $17.20 | decline depth |
| Red List |  MLYS |
Mineralys Therapeutics, Inc. | -44.6% | 4.2σ | 4/5 | $26.39 | decline depth |
| Red ListRecovering |  BAX |
Baxter International Inc. | -44.0% | 3.4σ | 4/5 | $17.79 | decline depth |
| Red ListRecovering |  VTYX |
Ventyx Biosciences, Inc. | -44.0% | — | 0/5 | $14.00 | decline depth |
| Red List |  HROW |
Harrow, Inc. | -43.7% | 4.7σ | 2/5 | $30.90 | decline depth |
| Red ListRecovering |  MOH |
Molina Healthcare Inc | -43.6% | 2.7σ | 3/5 | $184.88 | decline depth |
| Red List |  RARE |
Ultragenyx Pharmaceutical Inc. | -42.9% | 6.1σ | 5/5 | $24.19 | decline depth |
| Red List |  SGRY |
Surgery Partners, Inc. | -42.4% | 4.4σ | 3/5 | $13.92 | decline depth |
| Red List |  ALNY |
Alnylam Pharmaceuticals, Inc. | -42.2% | 5.3σ | 3/5 | $286.27 | decline depth |
| Red List |  PSNL |
Personalis, Inc. | -41.6% | 2.5σ | 1/5 | $6.72 | decline depth |
| Red ListRecovering |  SLNO |
Soleno Therapeutics, Inc. | -41.3% | 0.6σ | 5/5 | $53.01 | decline depth |
| Red List |  XRAY |
DENTSPLY SIRONA Inc. | -40.9% | 11.8σ | 1/5 | $9.82 | decline depth |
| Red List |  XNCR |
Xencor, Inc. | -40.8% | 5.4σ | 4/5 | $11.06 | decline depth |
| Red List |  RGEN |
Repligen Corporation | -40.7% | 7.4σ | 3/5 | $104.20 | decline depth |
| Red List |  XERS |
Xeris Biopharma Holdings, Inc. | -40.4% | 5.3σ | 4/5 | $6.01 | decline depth |
| Red List |  CRNX |
Crinetics Pharmaceuticals, Inc. | -40.2% | 5.0σ | 3/5 | $34.70 | decline depth |
| Red List |  ARVN |
Arvinas, Inc. | -39.5% | 8.6σ | 3/5 | $8.78 | decline depth |
| Red ListRecovering |  CNMD |
CONMED Corporation | -39.3% | 5.5σ | 5/5 | $36.61 | time-frame continuity |
| Red List |  VNDA |
Vanda Pharmaceuticals Inc. | -38.8% | 5.4σ | 2/5 | $6.08 | decline depth |
| Red List |  TECH |
Bio-Techne Corp | -38.4% | 5.6σ | 3/5 | $44.43 | decline depth |
| Red ListRecovering |  MMSI |
Merit Medical Systems, Inc. | -36.4% | 4.0σ | 5/5 | $63.64 | time-frame continuity |
| Red List |  IBRX |
ImmunityBio, Inc. | -35.6% | 2.3σ | 2/5 | $8.00 | decline depth |
| Red ListRecovering |  ABT |
Abbott Laboratories | -35.5% | 6.2σ | 5/5 | $87.91 | time-frame continuity |
| Red List |  KPTI |
Karyopharm Therapeutics Inc. | -35.0% | 6.5σ | 3/5 | $7.14 | decline depth |
| Red List |  VREX |
Varex Imaging Corporation | -33.4% | 5.3σ | 3/5 | $9.70 | decline depth |
| Red List |  DHR |
Danaher Corporation | -32.4% | 11.8σ | 4/5 | $163.86 | decline depth |
| Red ListRecovering |  INNV |
InnovAge Holding Corp. | -32.2% | 6.1σ | 1/5 | $7.25 | decline depth |
| Red List |  ALHC |
Alignment Healthcare, Inc. | -31.8% | 7.0σ | 3/5 | $16.28 | decline depth |
| Red List |  TMO |
Thermo Fisher Scientific Inc | -31.3% | 7.6σ | 2/5 | $442.00 | decline depth |
| Red List |  AMLX |
Amylyx Pharmaceuticals, Inc. | -30.9% | 12.3σ | 2/5 | $12.86 | decline depth |
| Red List |  ALMS |
Alumis Inc. | -30.9% | 6.6σ | 3/5 | $21.15 | decline depth |
| Red ListRecovering |  COR |
Cencora, Inc. | -30.4% | 5.1σ | 3/5 | $261.87 | decline depth |
| Red List |  RLAY |
Relay Therapeutics, Inc. | -30.1% | 8.2σ | 2/5 | $12.10 | decline depth |
| Red List |  COGT |
Cogent Biosciences, Inc. | -28.3% | 9.3σ | 1/5 | $31.36 | decline sigma |
| Red List |  IMNM |
Immunome, Inc. | -28.0% | 8.3σ | 3/5 | $19.90 | decline sigma |
| Red List |  STOK |
Stoke Therapeutics, Inc. | -27.8% | 11.8σ | 1/5 | $29.03 | decline sigma |
| Red ListRecovering |  CHE |
Chemed Corp | -24.4% | 1.7σ | 5/5 | $441.62 | time-frame continuity |
| Red List |  NVST |
Envista Holdings Corporation | -23.9% | 8.3σ | 1/5 | $23.15 | decline sigma |
| Red List |  ALGN |
Align Technology, Inc. | -23.8% | 10.9σ | 1/5 | $158.78 | decline sigma |
| Red List |  BBIO |
BridgeBio Pharma, Inc. | -23.1% | 9.1σ | 3/5 | $65.32 | decline sigma |
| Red List |  AMRX |
Amneal Pharmaceuticals, Inc. | -22.7% | 8.4σ | 3/5 | $11.92 | decline sigma |
| Red ListRecovering |  GMED |
Globus Medical, Inc. | -22.2% | 8.0σ | 2/5 | $78.93 | decline sigma |
| Red ListRecovering |  SYK |
Stryker Corporation | -22.1% | 4.3σ | 5/5 | $313.22 | time-frame continuity |
| Amber List |  CORT |
Corcept Therapeutics Incorporat | -39.4% | 1.8σ | 3/5 | $55.12 | decline depth |
| Amber List |  DCTH |
Delcath Systems, Inc. | -39.2% | 3.8σ | 1/5 | $11.09 | decline depth |
| Amber ListRecovering |  SPOK |
Spok Holdings, Inc. | -39.1% | 3.8σ | 3/5 | $10.99 | decline depth |
| Amber ListRecovering |  NEO |
NeoGenomics, Inc. | -39.1% | 6.6σ | 3/5 | $8.37 | decline depth |
| Amber List |  EYPT |
EyePoint, Inc. | -38.8% | 7.8σ | 3/5 | $11.70 | decline depth |
| Amber List |  ADPT |
Adaptive Biotechnologies Corpor | -38.8% | 6.0σ | 3/5 | $12.71 | decline depth |
| Amber List |  VERA |
Vera Therapeutics, Inc. | -38.7% | 5.7σ | 2/5 | $34.35 | decline depth |
| Amber ListRecovering |  AGIO |
Agios Pharmaceuticals, Inc. | -38.7% | 1.4σ | 2/5 | $28.21 | decline depth |
| Amber List |  BHC |
Bausch Health Companies Inc. | -38.5% | 6.8σ | 4/5 | $5.34 | decline depth |
| Amber ListRecovering |  EOLS |
Evolus, Inc. Common Stock | -38.1% | 1.2σ | 4/5 | $6.57 | decline depth |
| Amber List |  CRSP |
CRISPR Therapeutics AG | -38.1% | 4.3σ | 4/5 | $48.56 | decline depth |
| Amber List |  PHAT |
Phathom Pharmaceuticals, Inc. | -37.8% | 3.4σ | 4/5 | $11.39 | decline depth |
| Amber List |  IVA |
Inventiva S.A. - American Depos | -37.1% | 5.2σ | 2/5 | $5.02 | decline depth |
| Amber List |  ARQT |
Arcutis Biotherapeutics, Inc. | -37.0% | 4.1σ | 3/5 | $20.03 | decline depth |
| Amber List |  TENX |
Tenax Therapeutics, Inc. | -36.8% | 7.2σ | 2/5 | $11.62 | decline depth |
| Amber ListRecovering |  STVN |
Stevanato Group S.p.A. | -36.5% | 3.3σ | 4/5 | $17.79 | decline depth |
| Amber List |  BIOA |
BioAge Labs, Inc. | -36.1% | 4.9σ | 3/5 | $15.34 | decline depth |
| Amber List |  TDOC |
Teladoc Health, Inc. | -35.0% | 5.2σ | 2/5 | $6.35 | decline depth |
| Amber List |  ARDT |
Ardent Health, Inc. | -34.5% | 1.0σ | 3/5 | $10.14 | decline depth |
| Amber List |  CRL |
Charles River Laboratories Inte | -34.5% | 6.6σ | 1/5 | $149.93 | decline depth |
| Amber List |  HAE |
Haemonetics Corporation | -34.4% | 3.2σ | 2/5 | $57.28 | decline depth |
| Amber ListRecovering |  ATRC |
AtriCure, Inc. | -34.0% | 1.9σ | 3/5 | $28.48 | decline depth |
| Amber List |  DYN |
Dyne Therapeutics, Inc. | -33.8% | 5.2σ | 2/5 | $16.54 | decline depth |
| Amber List |  COLL |
Collegium Pharmaceutical, Inc. | -33.7% | 5.8σ | 3/5 | $33.65 | decline depth |
| Amber List |  OMER |
Omeros Corporation | -33.7% | 6.5σ | 3/5 | $11.70 | decline depth |
| Amber List |  VKTX |
Viking Therapeutics, Inc. | -33.5% | 7.1σ | 2/5 | $28.69 | decline depth |
| Amber ListRecovering |  MEDP |
Medpace Holdings, Inc. | -33.1% | 4.1σ | 1/5 | $420.67 | decline depth |
| Amber List |  IRON |
Disc Medicine, Inc. | -32.8% | 5.6σ | 2/5 | $66.85 | decline depth |
| Amber List |  FDMT |
4D Molecular Therapeutics, Inc. | -32.2% | 6.1σ | 2/5 | $8.37 | decline depth |
| Amber ListRecovering |  CBLL |
CeriBell, Inc. | -31.9% | 5.0σ | 1/5 | $16.58 | decline depth |
| Amber ListRecovering |  GEHC |
GE HealthCare Technologies Inc. | -31.5% | 5.3σ | 3/5 | $61.51 | decline depth |
| Amber ListRecovering |  ENOV |
Enovis Corporation | -31.4% | 2.7σ | 3/5 | $25.25 | decline depth |
| Amber ListRecovering |  UHS |
Universal Health Services, Inc. | -31.2% | 3.3σ | 4/5 | $169.27 | decline depth |
| Amber List |  NRIX |
Nurix Therapeutics, Inc. | -31.1% | 6.0σ | 3/5 | $15.51 | decline depth |
| Amber List |  INGN |
Inogen, Inc | -31.0% | 6.8σ | 2/5 | $6.30 | decline depth |
| Amber List |  CAPR |
Capricor Therapeutics, Inc. | -30.6% | 5.2σ | 1/5 | $28.02 | decline depth |
| Amber List |  GLUE |
Monte Rosa Therapeutics, Inc. | -30.1% | 5.8σ | 3/5 | $18.01 | decline depth |
| Amber ListRecovering |  A |
Agilent Technologies, Inc. | -30.1% | 4.8σ | 2/5 | $112.11 | decline depth |
| Amber ListRecovering |  IQV |
IQVIA Holdings, Inc. | -30.1% | 2.3σ | 2/5 | $172.81 | decline depth |
| Amber List |  RMD |
ResMed Inc. | -30.0% | 6.6σ | 3/5 | $204.15 | decline sigma |
| Amber List |  ATR |
AptarGroup, Inc. | -29.5% | 7.4σ | 2/5 | $115.81 | decline sigma |
| Amber ListRecovering |  IDXX |
IDEXX Laboratories, Inc. | -29.1% | 4.9σ | 4/5 | $545.79 | time-frame continuity |
| Amber List |  RYTM |
Rhythm Pharmaceuticals, Inc. | -28.9% | 3.7σ | 4/5 | $86.84 | time-frame continuity |
| Amber ListRecovering |  ALC |
Alcon Inc. | -28.4% | 6.0σ | 3/5 | $65.97 | decline sigma |
| Amber List |  IDYA |
IDEAYA Biosciences, Inc. | -27.9% | 7.5σ | 2/5 | $28.32 | decline sigma |
| Amber ListRecovering |  MDT |
Medtronic plc. | -26.1% | 6.3σ | 3/5 | $77.32 | decline sigma |
| Amber List |  PCVX |
Vaxcyte, Inc. | -25.5% | 6.8σ | 1/5 | $48.44 | decline sigma |
| Amber List |  BMRN |
BioMarin Pharmaceutical Inc. | -25.1% | 7.5σ | 3/5 | $49.67 | decline sigma |
| Amber ListRecovering |  ZBH |
Zimmer Biomet Holdings, Inc. | -20.8% | 4.0σ | 4/5 | $85.14 | time-frame continuity |
| Amber List |  BCAX |
Bicara Therapeutics Inc. | -20.4% | 7.3σ | 2/5 | $19.29 | decline sigma |
| Amber ListRecovering |  ANIP |
ANI Pharmaceuticals, Inc. | -20.3% | 6.1σ | 3/5 | $79.34 | decline sigma |
| Watch |  USPH |
U.S. Physical Therapy, Inc. | -29.6% | 3.6σ | 2/5 | $65.04 | decline depth |
| Watch |  MASS |
908 Devices Inc. | -28.9% | 4.4σ | 2/5 | $6.64 | decline depth |
| WatchRecovering |  HQY |
HealthEquity, Inc. | -28.8% | 2.7σ | 2/5 | $83.04 | decline depth |
| Watch |  ABEO |
Abeona Therapeutics Inc. | -28.8% | 4.1σ | 3/5 | $5.37 | decline depth |
| WatchRecovering |  OFIX |
Orthofix Medical Inc. | -28.6% | 2.8σ | 3/5 | $12.14 | decline depth |
| Watch |  QTTB |
Q32 Bio Inc. | -28.5% | 3.7σ | 0/5 | $5.75 | decline depth |
| Watch |  ELAN |
Elanco Animal Health Incorporat | -28.1% | 5.2σ | 1/5 | $19.93 | decline depth |
| WatchRecovering |  DXCM |
DexCom, Inc. | -27.7% | 1.8σ | 1/5 | $65.09 | decline depth |
| WatchRecovering |  ITGR |
Integer Holdings Corporation | -27.3% | 1.3σ | 1/5 | $89.97 | decline depth |
| Watch |  ARDX |
Ardelyx, Inc. | -27.3% | 5.4σ | 3/5 | $6.11 | decline depth |
| Watch |  FTRE |
Fortrea Holdings Inc. | -27.2% | 3.0σ | 1/5 | $13.59 | decline depth |
| Watch |  ACAD |
ACADIA Pharmaceuticals Inc. | -27.0% | 4.7σ | 2/5 | $20.69 | decline depth |
| Watch |  HRMY |
Harmony Biosciences Holdings, I | -27.0% | 5.5σ | 2/5 | $29.83 | decline depth |
| Watch |  BEAM |
Beam Therapeutics Inc. | -26.4% | 4.4σ | 3/5 | $26.81 | decline depth |
| Watch |  KURA |
Kura Oncology, Inc. | -26.3% | 3.9σ | 3/5 | $9.20 | decline depth |
| Watch |  TARS |
Tarsus Pharmaceuticals, Inc. | -26.3% | 2.4σ | 2/5 | $62.82 | decline depth |
| Watch |  NVAX |
Novavax, Inc. | -25.4% | 4.0σ | 2/5 | $8.93 | decline depth |
| Watch |  AVAH |
Aveanna Healthcare Holdings Inc | -25.4% | 1.5σ | 3/5 | $7.70 | decline depth |
| Watch |  NTRA |
Natera, Inc. | -24.9% | 3.8σ | 2/5 | $192.54 | decline depth |
| WatchRecovering |  BLFS |
BioLife Solutions, Inc. | -24.7% | 3.2σ | 3/5 | $22.30 | decline depth |
| WatchRecovering |  VCEL |
Vericel Corporation | -24.1% | 5.6σ | 1/5 | $34.87 | decline depth |
| Watch |  SNDX |
Syndax Pharmaceuticals, Inc. | -24.1% | 4.9σ | 1/5 | $19.41 | decline depth |
| Watch |  HCA |
HCA Healthcare, Inc. | -23.9% | 5.0σ | 3/5 | $422.79 | decline depth |
| Watch |  BRKR |
Bruker Corporation | -23.9% | 1.6σ | 2/5 | $42.75 | decline depth |
| WatchRecovering |  KIDS |
OrthoPediatrics Corp. | -23.5% | 2.0σ | 2/5 | $18.14 | decline depth |
| WatchRecovering |  ICUI |
ICU Medical, Inc. | -23.2% | 4.9σ | 2/5 | $123.08 | decline depth |
| Watch | TECTECX | Tectonic Therapeutic, Inc. | -23.1% | 3.0σ | 2/5 | $27.70 | decline depth |
| WatchRecovering |  TBPH |
Theravance Biopharma, Inc. | -22.7% | 4.9σ | 2/5 | $16.26 | decline depth |
| WatchRecovering |  SHC |
Sotera Health Company | -22.7% | 5.2σ | 3/5 | $15.35 | decline depth |
| Watch |  KYMR |
Kymera Therapeutics, Inc. | -22.6% | 5.3σ | 2/5 | $79.67 | decline depth |
| Watch |  DNLI |
Denali Therapeutics Inc. | -22.6% | 3.9σ | 0/5 | $18.40 | decline depth |
| WatchRecovering |  BKD |
Brookdale Senior Living Inc. | -22.3% | 5.1σ | 2/5 | $13.28 | decline depth |
| Watch |  THC |
Tenet Healthcare Corporation | -22.1% | 1.7σ | 2/5 | $192.45 | decline depth |
| WatchRecovering |  ENTA |
Enanta Pharmaceuticals, Inc. | -21.6% | 5.8σ | 3/5 | $13.45 | decline depth |
| Watch |  OMCL |
Omnicell, Inc. | -21.4% | 1.6σ | 1/5 | $43.22 | decline depth |
| Watch |  ESTA |
Establishment Labs Holdings Inc | -21.2% | 4.1σ | 3/5 | $65.63 | decline depth |
| Watch |  UFPT |
UFP Technologies, Inc. | -21.0% | 3.1σ | 3/5 | $217.22 | decline depth |
| WatchRecovering |  ANGO |
AngioDynamics, Inc. | -20.9% | 2.8σ | 2/5 | $11.07 | decline depth |
| Watch |  STE |
STERIS plc (Ireland) | -20.8% | 3.7σ | 2/5 | $212.87 | decline depth |
| Watch |  GH |
Guardant Health, Inc. | -20.8% | 2.8σ | 3/5 | $95.66 | decline depth |
| Watch |  BCRX |
BioCryst Pharmaceuticals, Inc. | -20.7% | 3.1σ | 1/5 | $8.97 | decline depth |
| Watch |  MGTX |
MeiraGTx Holdings plc | -20.7% | 5.1σ | 3/5 | $9.40 | decline depth |
| WatchRecovering |  SNN |
Smith & Nephew SNATS, Inc. | -20.0% | 5.8σ | 2/5 | $30.30 | decline depth |
199 Healthcare listings. Open in the full filterable list →